# $5 1 0 ( k )$ Summary

This summary of $5 1 0 ( k )$ safety and effectiveness information is being submitted in accordance with the requirements of 21 CFR 807.92

The Assigned 510(k) Number is: k093384   
Applicant: Diamond Diagnostics, Inc. 333 Fiske Street Holliston, MA 01746

# Contact Person:

Kathy Cruz Qaulity Assurance Manager Phone: (508) 429-0450 ext. 358 Fax: (508) 429-0452

# Date Prepared:

March 4, 2010

Controls:   
Classification Name:   
Trade Name:   
Device Classification:   
Device Class:   
Classification Panel:   
Product Code:   
Controls for blood-gases (Assayed and Un-Assayed)   
Mission Trinity R   
21 CFR 862.1660   
Class I   
Clinical Chemistry   
JJY

# Intended Use:

Mission Trinity $\bar { \mathsf { R } } ^ { \bar { \mathsf { M } } }$ Control is intended to be used as an assayed quality contro! material for monitoring the precision and performance of the following analytes pH, $p C O _ { 2 } ,$ $p { \mathsf { O } } _ { 2 }$ ${ \mathsf { N a } } ^ { + }$ s $\mathsf { K } ^ { + }$ , ${ \tt C a } ^ { + + }$ , $\mathtt { c l }$ , glucose, and lactate on blood gas, electrolyte, and metabolite analyzers as well as tHb, $\% 0 . 1 H b$ , $\% 0 . 5 a t$ %COHb, %MetHb, $\% O _ { 2 } C t$ & %HHb on COOximeter instrumentation. It is for in vitro diagnostics use and for the quantitative determination of the analytes listed on the Expected Values Chart.

# Device Description:

Trinity R matrix consists of a buffered solution of electrolytes, glucose, lactate, dyes and preservative. It is equifibrated with specific levels of $\mathsf { C O } _ { 2 }$ $\mathsf { O } _ { 2 }$ and $N _ { 2 }$ It contains no human or biological materials. Trinity R is provided in three (3) distinct levels of pH, $p C O _ { 2 } ,$ . $p { \mathsf { O } } _ { 2 }$ $N a ^ { + }$ , $\mathsf { K } ^ { + }$ $\mathtt { C a } ^ { + + }$ , Cl, glucose, lactate, tHb, $\% 0 . 1 H b$ , $\% H b 0 _ { z } S { \sf a t }$ , %COHb, %MetHb, $\% O _ { 2 } C t$ & %HHb cover ing the significant range of the instrument performance. It is packaged in sealed glass ampules, each containing $1 . 8 \ m |$ of solution. Ampules are packaged in single level boxes (30 ampules of same level) or tri-level boxes (10 ampules of each level).

# Predicate Device name:

RNA Medical RA 525 Blood Gas, Electrolyte, Metabolite, CO-OXimeter (Radiometer) Control

Predicate $5 1 0 ( k )$ number(s): K880447

# Comparison with predicate:

Simitarities   

<table><tr><td rowspan=1 colspan=1>Characteristics</td><td rowspan=1 colspan=1>Mission Trinity R</td><td rowspan=1 colspan=1>RNA Medical RA 525 Blood Gas,Electrolyte, Metabolite, CO-OXimeter(Radiometer)</td></tr><tr><td rowspan=1 colspan=1>510(K) Number</td><td rowspan=1 colspan=1>K093384</td><td rowspan=1 colspan=1>K880447</td></tr><tr><td rowspan=1 colspan=1>Product Type</td><td rowspan=1 colspan=1>Assayed Blood Gas Control</td><td rowspan=1 colspan=1>Assayed Blood Gas Control</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>For in vitro diagnostics use for quality controlof pH/Blood Gas analyzers, ISE analyzers,Metabolite analyzers and CO-OXimeterInstrumentation.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Matrix</td><td rowspan=1 colspan=1>Buffered Aqueous Solution</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Storage</td><td rowspan=1 colspan=1>2-8</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Color</td><td rowspan=1 colspan=1>Red/purple solution</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Levels</td><td rowspan=1 colspan=1>Three</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Analytes</td><td rowspan=1 colspan=1>pH, pCO2, pO2, Na&quot;, K*, Ca**, Cl, glucose,lactate, tHb, %02Hb, %COHb, %metHb,%02Ct, %O2Sat and %HHb</td><td rowspan=1 colspan=1>pH, pCO2, pO2, Na*, K*, Ca**, Cr, glucose,lactate, tHb, %O2Hb, %COHb, %metHb,%02Ct, %02Sat and %HHb</td></tr></table>

Differences   

<table><tr><td rowspan=1 colspan=1>Characteristics</td><td rowspan=1 colspan=1>Mission Trinity R</td><td rowspan=1 colspan=1>RNA Medical RA 525 Blood Gas,Electrolyte, Metabolite, CO-OXimeter(Radiometer)</td></tr><tr><td rowspan=1 colspan=1>Preservative</td><td rowspan=1 colspan=1>Present</td><td rowspan=1 colspan=1>Not present</td></tr><tr><td rowspan=1 colspan=1>Package</td><td rowspan=1 colspan=1>30 X 1.8mL</td><td rowspan=1 colspan=1>30 X 2.5mL</td></tr><tr><td rowspan=1 colspan=1>Shelf Life</td><td rowspan=1 colspan=1>24 months</td><td rowspan=1 colspan=1>36 months</td></tr></table>

# Substantial Equivalence Discussion

Mission claims substantial equivalence to RNA Medical RA525 Controls listed below:

# Substantial Equivalence Table of Product PN's & Trade Names

<table><tr><td>Mission Product</td><td colspan="2">RNA Medical RA 525</td><td>RNA Medical RA 525 Blood Gas,</td></tr><tr><td>DD-97001D</td><td>Mission Trinity R Control (Level 1)</td><td>RA 525-1</td><td>Electrolyte, Metabolite, CO- OXimeter (Radiometer) Control (Level 1) RNA Medical RA 525 Blood Gas,</td></tr><tr><td>DD-97002D</td><td>Mission Trinity R Control (Level 2)</td><td>RA 525-2</td><td>Electrolyte, Metabolite, CO- OXimeter (Radiometer) Control (Level 2) RNA Medical RA 525 Blood Gas,</td></tr><tr><td>DD-97003D</td><td>Mission Trinity R Control (Level 3)</td><td>RA 525-3</td><td>Electrolyte, Metabolite, CO- OXimeter (Radiometer) Control (Level 3) RNA Medical RA 525 Blood Gas,</td></tr><tr><td>DD-97123</td><td>Mission Trinity  Control (Multi- Level</td><td>RA 525</td><td>Electrolyte, Metabolite, CO- OXimeter (Radiometer) Control (Multi-Level)</td></tr></table>

Misson clais ubstantial equivalenceAMedical RArCoositon, ItenduseackaginStor Shelf life.

The tables below compare Mission to RNA Medical RA525.

Comparison Tables of Characteristics - Mission vs RNA Medical - by product   

<table><tr><td rowspan=1 colspan=1>Characteristics</td><td rowspan=1 colspan=1>Mission Trinity R</td><td rowspan=1 colspan=1>RNA Medical RA 525 Blood Gas,Electrolyte, Metabolite, CO-OXimeter(Radiometer) k880447</td></tr><tr><td rowspan=1 colspan=1>Product Type</td><td rowspan=1 colspan=1>Assayed Blood Gas Control</td><td rowspan=1 colspan=1>Assayed Blood Gas Control</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>For in vitro diagnostics use for quality controlof pH/Blood Gas analyzers, ISE analyzers,Metabolite analyzers and CO-OXimeterInstrumentation.</td><td rowspan=1 colspan=1>For in vitro diagnostics use for qualitycontrol of pH/Blood Gas analyzers, ISEanalyzers, Metabolite analyzers and CO-OXimeter Instrumentation.</td></tr><tr><td rowspan=1 colspan=1>Matrix</td><td rowspan=1 colspan=1>Buffered Aqueous Solution</td><td rowspan=1 colspan=1>Buffered Aqueous Solution</td></tr><tr><td rowspan=1 colspan=1>Storage</td><td rowspan=1 colspan=1>2-8</td><td rowspan=1 colspan=1>2-8Â°</td></tr><tr><td rowspan=1 colspan=1>Color</td><td rowspan=1 colspan=1>Red/purple solution</td><td rowspan=1 colspan=1>Red/purple solution</td></tr><tr><td rowspan=1 colspan=1>Levels</td><td rowspan=1 colspan=1>1, 2, 3</td><td rowspan=1 colspan=1>1,2,3</td></tr><tr><td rowspan=1 colspan=1>Analytes</td><td rowspan=1 colspan=1>pH, pCO2, pO2, Na*, K*, Ca*, Cl, glucose,lactate, tHb, %02Hb, %COHb, %metHb,%02Ct, %02Sat and %HHb</td><td rowspan=1 colspan=1>pH, pCO2, pO2, Na*, K*, Ca**, Cl, glucose,lactate, tHb, %O2Hb, %COHb, %metHb,%02Ct, %02Sat and %HHb</td></tr><tr><td rowspan=1 colspan=1>Preservative</td><td rowspan=1 colspan=1>Present</td><td rowspan=1 colspan=1>Not present</td></tr><tr><td rowspan=1 colspan=1>Package</td><td rowspan=1 colspan=1>30 X 1.8mL</td><td rowspan=1 colspan=1>30 X 2.5mL</td></tr><tr><td rowspan=1 colspan=1>Shelf Life</td><td rowspan=1 colspan=1>24 months</td><td rowspan=1 colspan=1>36 months</td></tr></table>

Diamond Diagnostics Inc.   
c/o Kathy Cruz   
333 Fiske Street   
Holliston, Massachusetts 01746

MAR 10 2010

Re: k093384 Trade Name: Mission Trinity R Blood Gas Controls Regulation Number: 21 CFR $\ S 8 6 2 . 1 6 6 0$ Regulation Name: Quality Control Material Assayed and Unassayed. Regulatory Class: Class I, reserved Product Codes: JJY Dated: January 4, 2010 Received: January 4, 2010

Dear Ms. Cruz:

We have reviewed your Section $5 1 0 ( \mathrm { k } )$ premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (301) 796-5760. For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (.301 ) 796-5680 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

![](images/c6fa8c6218fb718c31329ac3ed873d8c8c84b0276a05e913f3d396a61c7be399.jpg)

Courtny C. Harper, Ph.D.   
Directr   
Division of Chemistry and Toxicology   
Office of In Vitro Diagnostic Device   
Evaluation and Safety   
Center for Devices and Radiological Health

Enclosure

Indications for Use 510k) Numbero K93384

Device Name: Mission Trinity R

Indications for Use:

Mission Trinity $\mathsf { R } ^ { \mathsf { T M } }$ Control is intended to be used as an assayed quality control material for monitoring the precision and performance of the following analytes pH, ${ \mathsf { p C O } } _ { 2 }$ $p { \mathsf { O } } _ { 2 } ,$ $N a ^ { + }$ . $\mathsf { K } ^ { \star }$ $\mathsf { C a } ^ { + + }$ $\textstyle \mathtt { C F }$ , glucose, and lactate on blood gas, electrolyte, and metabofite analyzers as well as tHb, $\% O _ { 2 } |$ b, $\% 0 . 5 2 1$ , %COHb, %MetHb, $\% 0 _ { 2 } \mathrm { C t }$ & %HHb on COOximeter instrumentation.

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)-

![](images/2ad3ef7628f66f249279ed5187a6802c098220339a9d71fabf98c09312ee9cfc.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

510(k) (k 093384

1of 1